Sudhakara Reddy Madduri

Title: Sudhakara Reddy Madduri: Pharmaceutical Patent Inventor

Introduction

Sudhakara Reddy Madduri is an inventor based in Bengaluru, India, whose patent work focuses on compounds that activate formyl peptide receptors. He is associated with Bristol Myers Squibb. His listed portfolio includes 2 patents.

Latest Patents

“Oxopyrrolidine FPR2 Agonists” describes compounds that act as agonists of the formyl peptide 2 (FPR2) receptor and/or the formyl peptide 1 (FPR1) receptor. The disclosure also covers compositions and methods for using the compounds, including potential treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.

“Oxopyrrolidine Urea FPR2 Agonists” likewise concerns compounds that activate FPR2 and/or FPR1 receptors. It describes compositions and methods of use, including potential applications in treating atherosclerosis, heart failure, COPD, and related diseases.

Career Highlights

Madduri’s listed patent work centers on medicinal chemistry and receptor-targeted compounds with potential applications in cardiovascular and respiratory diseases. His association with Bristol Myers Squibb places this work within a pharmaceutical research and development setting.

Collaborations

Ellen K. Kick and Vishweshwaraiah Baligar are identified as Madduri’s coworkers. The available information does not specify their roles in the listed patent disclosures.

Conclusion

Sudhakara Reddy Madduri’s two listed patents describe related oxopyrrolidine compounds targeting FPR2 and FPR1, with potential therapeutic applications across several serious diseases.